Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model

Mutations in the VAV1 guanine nucleotide exchange factor 1 have been recently found in peripheral T cell lymphoma and nonsmall-cell lung cancer (NSCLC). To understand their pathogenic potential, we generated a gene-edited mouse model that expresses a VAV1 mutant protein that recapitulates the signal...

ver descrição completa

Detalhes bibliográficos
Autores: Robles-Valero, Javier; Fernández-Nevado, Lucía; Cuadrado, Myriam; Lorenzo-Martín, L. Francisco; Fernández-Pisonero, Isabel; Abad, Antonio; Redín, Esther; Montuenga, Luis; Martín-Zanca, Dionisio; Bigas Salvans, Anna; Mallo, Moises; Dosil, Mercedes; Bustelo, Xose R.
Tipo de documento: Artigo
Estado:Published version
Data de publicação:2022
País:España
Recursos:Universitat Pompeu Fabra
Repositório:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/55662
Acesso em linha:http://hdl.handle.net/10230/55662
http://dx.doi.org/10.1002/1878-0261.13295
Nível de acesso:Acesso aberto
Palavra-chave:RAC1
TP53
Angioimmunoblastic T cell lymphoma
Follicular helper T cells
Nonsmall-cell lung cancer
Peripheral T cell lymphoma
Descrição
Resumo:Mutations in the VAV1 guanine nucleotide exchange factor 1 have been recently found in peripheral T cell lymphoma and nonsmall-cell lung cancer (NSCLC). To understand their pathogenic potential, we generated a gene-edited mouse model that expresses a VAV1 mutant protein that recapitulates the signalling alterations present in the VAV1 mutant subclass most frequently found in tumours. We could not detect any overt tumourigenic process in those mice. However, the concurrent elimination of the Trp53 tumour suppressor gene in them drives T cell lymphomagenesis. This process represents an exacerbation of the normal functions that wild-type VAV1 plays in follicular helper T cells. We also found that, in combination with the Kras oncogene, the VAV1 mutant version favours progression of NSCLC. These data indicate that VAV1 mutations play critical, although highly cell-type-specific, roles in tumourigenesis. They also indicate that such functions are contingent on the mutational landscape of the tumours involved.